Cytarabine Dose for Acute Myeloid Leukemia REPLY

被引：0
|
作者：
Lowenberg, Bob [1 ]
机构：
[1] Erasmus Univ, Med Ctr, Rotterdam, Netherlands
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2011年 / 364卷 / 22期
关键词：
CHEMOTHERAPY; THERAPY; INDUCTION; ADULTS;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2168 / 2169
页数：2
相关论文
共 50 条
  • [41] Does High-Dose Cytarabine Cause More Fungal Infection in Patients With Acute Myeloid Leukemia Undergoing Consolidation Therapy A Multicenter, Prospective, Observational Study in China
    Wang, Ling
    Hu, Jiong
    Sun, Yuqian
    Huang, He
    Chen, Jing
    Li, Jianyong
    Ma, Jun
    Li, Juan
    Liang, Yingmin
    Wang, Jianmin
    Li, Yan
    Yu, Kang
    Hu, Jianda
    Jin, Jie
    Wang, Chun
    Wu, Depei
    Xiao, Yang
    Huang, Xiaojun
    MEDICINE, 2016, 95 (04)
  • [42] Mitoxantrone and etoposide with or without intermediate dose cytarabine for the treatment of primary induction failure or relapsed acute myeloid leukemia
    Trifilio, Steven M.
    Rademaker, Alfred W.
    Newman, Diane
    Coyle, Katherine
    Carlson-Leuer, Katrin
    Mehta, Jayesh
    Altman, Jessica
    Frankfurt, Olga
    Tallman, Martin S.
    LEUKEMIA RESEARCH, 2012, 36 (04) : 394 - 396
  • [43] Institutional Experience With Clofarabine and Cytarabine in Relapsed Pediatric Acute Myeloid Leukemia
    Moreno, Lucas
    Maria Fernandez-Navarro, Jose
    del Mar Andres, Maria
    Bautista, Francisco
    Tasso, Maria
    Verdeguer, Amparo
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2012, 34 (01) : E17 - E21
  • [44] Activity of the Multikinase Inhibitor Sorafenib in Combination With Cytarabine in Acute Myeloid Leukemia
    Hu, Shuiying
    Niu, Hongmei
    Inaba, Hiroto
    Orwick, Shelley
    Rose, Charles
    Panetta, John C.
    Yang, Shengping
    Pounds, Stanley
    Fan, Yiping
    Calabrese, Christopher
    Rehg, Jerold E.
    Campana, Dario
    Rubnitz, Jeffrey E.
    Baker, Sharyn D.
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (11) : 893 - 905
  • [45] Intensified induction chemotherapy with high dose cytarabine and etoposide for acute myeloid leukemia: A review and updated results of the Australian Leukemia Study Group
    Bishop, JF
    Matthews, JP
    Young, GAR
    Bradstock, K
    Lowenthal, RM
    LEUKEMIA & LYMPHOMA, 1998, 28 (3-4) : 315 - 327
  • [46] Venetoclax plus daunorubicin and cytarabine in newly diagnosed acute myeloid leukemia patients: A propensity score-matched analysis
    Wang, Rong
    Zhang, Yi
    Chang, Jie
    Wang, Huafeng
    Lou, Yinjun
    Yang, Min
    Xu, Gaixiang
    Tong, Hongyan
    Xie, Wanzhuo
    Zhou, De
    Wei, Juying
    Mai, Wenyuan
    Ye, Xiujin
    Meng, Haitao
    Jin, Jie
    Zhu, Hong-Hu
    HEMATOLOGICAL ONCOLOGY, 2024, 42 (02)
  • [47] Combination of cladribine and cytarabine is effective for childhood acute myeloid leukemia: results of the St Jude AML97 trial
    Rubnitz, J. E.
    Crews, K. R.
    Pounds, S.
    Yang, S.
    Campana, D.
    Gandhi, V. V.
    Raimondi, S. C.
    Downing, J. R.
    Razzouk, B. I.
    Pui, C-H
    Ribeiro, R. C.
    LEUKEMIA, 2009, 23 (08) : 1410 - 1416
  • [48] A real-world study of clofarabine and cytarabine combination therapy for patients with acute myeloid leukemia
    He, Fiona
    Sapkota, Smarika
    Parker, Sarah
    Defor, Todd
    Warlick, Erica
    Ustun, Celalettin
    Eckfeldt, Craig
    Rashidi, Armin
    Kurtzweil, Andy
    Weisdorf, Daniel
    Bejanyan, Nelli
    LEUKEMIA & LYMPHOMA, 2018, 59 (10) : 2352 - 2359
  • [49] Increased Expression of Micro-RNA-23a Mediates Chemoresistance to Cytarabine in Acute Myeloid Leukemia
    Hatzl, Stefan
    Perfler, Bianca
    Wurm, Sonja
    Uhl, Barbara
    Quehenberger, Franz
    Ebner, Susanne
    Troppmair, Jakob
    Reinisch, Andreas
    Woelfler, Albert
    Sill, Heinz
    Zebisch, Armin
    CANCERS, 2020, 12 (02)
  • [50] Liposomal encapsulated cytarabine and daunorubicin (CPX-351) for older patients with acute myeloid leukemia
    Asghari, Hannah
    Lancet, Jeffrey
    LEUKEMIA & LYMPHOMA, 2020, 61 (06) : 1305 - 1312
12345